Health sensor platform 3.0 reduces development time by at least 6 months
Article By : Maxim Integrated
MAXREFDES104# is a wrist form factor reference design ready to collect blood oxygen, ECG, heart rate, body temperature and activity data
Save at least six months of development time using the Health Sensor Platform 3.0 (HSP 3.0) from Maxim Integrated Products, Inc. Also known as MAXREFDES104#, this ready-to-wear wrist form factor reference design monitors blood oxygen saturation (SpO2), electrocardiogram (ECG), heart rate (HR), body temperature and motion. Included algorithms provide HR, heart-rate variability (HRV), respiration rate (RR), SpO2 , body temperature, sleep quality and stress level information at clinical-grade levels. It allows wearable designers to start collecting data immediately, saving at least six months over building these devices from scratch. Designed for wrist-based form factors, HSP 3.0 can be adapted for other dry electrode form factors such as chest patches and smart rings.
Compared to its industry-leading predecessor, Health Sensor Platform 2.0 (HSP 2.0), the HSP 3.0 adds optical SpO2 measurement and dry-electrode capability to the ECG. As a result, it can enable end solutions to monitor cardiac heart and respiratory issues for management of ailments like chronic obstructive pulmonary disease (COPD), infectious diseases (e.g. COVID-19), sleep apnea and atrial fibrillation (AFib). Compared to its predecessor, the narrower form factor and enhanced optical architecture of HSP 3.0 improves signal acquisition quality and uses upgraded microcontroller, power, security and sensing ICs. The reference design includes complete optical and electrode designs, along with algorithms to meet clinical requirements.
Maxim Integrated is at the forefront of the wearable healthcare and remote patient monitoring revolution, enabling personalized healthcare as well as better predictive and preventive healthcare solutions. Medical professionals and end-users are using the wealth of health insights from these wearables. They can more proactively manage chronic conditions, diagnose acute conditions like COVID-19, and also improve preventive care and overall well-being. As more sensing modalities are included in wearables, device developers can take advantage of multiple measurements to improve accuracy of the actionable insights that are being provided to users.
Key Advantages
- Faster Time to Market:Saves at least six months in development time
- Clinical-Grade:Accuracy meets regulatory requirements for SpO2 and ambulatory ECG (IEC 60601-2-47)
- Covers Key Vital Signs: Addresses the needs of advanced health wearables with SpO2, ECG, HR, HRV, RR, body temperature and motion
- Complete Reference Design: Empowers designers to innovate with complete access to source code and design files
